Search Results for "Multiple Indicators Multiple Causes"
Matching Channels
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference i...
Matching News
Bristol-Myers Squibb joins Multiple Myeloma Research Foundation for multiple myeloma treatment
The Multiple Myeloma Research Foundation announced that Bristol-Myers Squibb has joined the MMRF pre-competitive consortium to discover and accelerate new approaches to treating multiple myeloma throu...
Multiple Births Affected By Congenital Anomalies Have Doubled Since The 1980s
The number of congenital anomalies, or birth defects arising from multiple births has almost doubled since the 1980s, suggests a new study published in BJOG: An International Journal of Obstetrics and...
Whole genome sequencing reveals underlying genetics of multiple myeloma
Dr Keats talks to ecancertv at the 14th International Multiple Myeloma Conference in Kyoto, Japan, 4th April 2013. Dr Keats and his team have been looking at the genomes of around 260 multiple myeloma...
Recent advances in multiple myeloma, featuring Educational Updates from ASH 2012
Professor Gareth Morgan from London, UK, leads an expert panel discussing key topics from the Multiple Myeloma Debate 2012 in Berlin for ecancer.TV, as well as the changing treatment landscape in mult...
MMRF joins multiple myeloma community in celebrating FDA accelerated approval of Pomalyst
The Multiple Myeloma Research Foundation (MMRF) today joined the multiple myeloma community in celebrating the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval of Pomal...
FDA approves Celgene drug for hard-to-treat multiple myeloma
(Reuters) - U.S. regulators have approved a new drug from Celgene Corp for patients with the multiple myeloma who have failed multiple alternative therapies.
New Frontline Treatment Regimen For Multiple Myeloma
Results from a study published online in Blood, the Journal of the American Society of Hematology (ASH), demonstrate that inclusion of carfilzomib, a novel targeted therapy for multiple myeloma, in co...
Changes in Corpus Callosum Area Indicate Progression to MS
Changes in the area of the corpus callosum on MRI and T2 lesion volume are the most sensitive of the MRI indicators of the risk for progression from clinically isolated syndrome to multiple sclerosis....
Matching PubMed Articles
Use of multiple colorimetric indicators for paper-based microfluidic devices.
We report here the use of multiple indicators for a single analyte for paper-based microfluidic devices (muPAD) in an effort to improve the ability to visually discriminate between analyte concentrati...
The Symptom Validity Scale (SVS) for low-functioning individuals (Chafetz, Abrahams, & Kohlmaier, 2007) employs embedded indicators within the Social Security Psychological Consultative Examination (P...
Abstract Multiple myeloma is a common hematological malignancy that urgently requires new approaches to treatment since the disease is not curable using current chemotherapeutic regimens. The aim of t...
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis.
Retrovirus-like particles containing the multiple sclerosis-associated retrovirus RNA, significantly found in the cerebrospinal fluid of patients with multiple sclerosis, have been preliminarily assoc...
It is important to know the comprehensive microbial communities of fecal pollution sources and receiving water bodies for microbial source tracking. Pyrosequencing targeting the V1-V3 hypervariable re...
